Urinary Retention

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
ColoplastAustralia - Mulgrave
2 programs
Investigational device - intermittent catheter with micro-hole zoneN/A1 trial
SpeediCath® cathetersN/A1 trial
Active Trials
NCT05485935CompletedEst. Jan 2023
NCT05065255UnknownEst. Jan 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ColoplastInvestigational device - intermittent catheter with micro-hole zone
ColoplastSpeediCath® catheters

Clinical Trials (2)

NCT05485935ColoplastInvestigational device - intermittent catheter with micro-hole zone

A Confirmatory Study Confirming Performance of a New Intermittent Catheter

Start: Aug 2022Est. completion: Jan 2023
N/ACompleted
NCT05065255ColoplastSpeediCath® catheters

Study of the Criteria for Choosing Speedicath Catheters During the Initiation of Self-catheterization

Start: Sep 2021Est. completion: Jan 2023
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space